GlassScriptPhysician profile
Alex C Liu
NPI 1275553158
$2,669.88
in general payments reported to CMS, 2019-2025
18 companies · $1,780 in 2025
The $1,780 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $229 · 2021: $187 · 2022: $231 · 2024: $21.05 · 2025: $1,780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $300.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $1,500.00 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Bausch & Lomb Americas INC. | $279.92 | 2025 | Envista Envy Iol, Stellaris |
| Allergan, INC. | $180.98 | 2019-2022 | |
| Alcon Vision LLC | $151.45 | 2020-2022 | |
| Horizon Therapeutics Plc | $122.48 | 2022 | |
| Covidien LP | $91.59 | 2019 | |
| Aerie Pharmaceuticals, INC. | $90.75 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $62.31 | 2019-2021 | |
| Abbott Laboratories | $51.82 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $36.34 | 2020 | |
| Ethicon US, LLC | $23.01 | 2021 | |
| Revance Therapeutics, INC. | $21.05 | 2024 | Daxxify |
| Dompe US, INC. | $15.74 | 2020 | |
| Sun Pharmaceutical Industries INC. | $14.22 | 2021 | |
| Boston Scientific Corporation | $11.27 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akorn, INC. | $10.86 | 2019 | |
| Alimera Sciences, INC. | $6.09 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.